Русский
The use of integrative indicators based on laboratory data to assess the efficiency of the current epidemiological surveillance system
DOI: https://dx.doi.org/10.18565/epidem.2025.15.1.35-42
Dubodelov D.V., Akimkin V.G., Semenenko T.A., Esman A.S., Kuzin S.N., Ugleva S.V., Voronin E.M., Gerasimov A.N., Cherkashina A.S., Khafizov K.F., Sycheva N.V., Korabelnikova M.I., Monakhova A.A., Beregovykh R.M.
1) Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; 2) N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Moscow, Russia
Materials and methods. The calculation and analysis of integrative indicators was carried out based on the results of PCR studies for the presence of SARS-CoV-2 RNA according to the SOLAR (System of Laboratory Aggregation Result) platform and information on the incidence of COVID-19 in the constituent entities of the Russian Federation for the period 2022–2023.
Results. It is shown that the results of PCR studies can be used to assess the dynamics of the epidemic process. Methods for assessing the completeness and objectivity of morbidity data in the constituent entities of the Russian Federation using integrative indicators are proposed. The use of integrative indicators to identify regional characteristics in the diagnosis and recording of COVID-19 cases is substantiated.
Conclusion. Integrative indicators based on morbidity data and laboratory data can be successfully used as criteria for assessing the completeness and objectivity of information in epidemiological analysis. They can also serve as a basis for comparative and operational assessment of the effectiveness of the epidemiological surveillance system.
Literature
1. Попова А.Ю., Ежлова Е.Б., Смоленский В.Ю., Брагина И.В., Орлов М.Ю., Демина Ю.В. и др. COVID-19: научно-практические аспекты борьбы с пандемией в Российской Федерации. Саратов: ООО «Амирит», 2021. 608 с.
Popova A.Yu., Ezhlova E.B., Smolenskij V.Yu., Bragina I.V., Orlov M.Yu., Demina Yu.V. et al. [COVID–19: scientific and practical aspects of combating the pandemic in the Russian Federation]. Saratov: Amirit, 2021. 608 p. (In Russ.).
2. Акимкин В.Г., Семененко Т.А., Хафизов К.Ф., Углева С.В., Дубоделов Д.В., Колосовская Е.Н. Стратегия геномного эпидемиологического надзора. Проблемы и перспективы. Журнал микробиологии, эпидемиологии и иммунобиологии 2024; 101(2): 163–172. DOI: 10.36233/0372-9311-507
Akimkin V.G., Semenenko T.A., Khafizov K.F., Ugleva S.V., Dubodelov D.V., Kolosovskaia E.N. [Genomic surveillance strategy. Problems and perspectives]. Journal of Microbiology, Epidemiology and Immunobiology 2024; 101(2): 163–172. (In Russ.). DOI: 10.36233/0372-9311-507
3. Акимкин В.Г., Семененко Т.А., Углева С.В., Дубоделов Д.В., Кузин С.Н., Яцышина С.Б. и др. COVID-19 в России: эпидемиология и молекулярно-генетический мониторинг. Вестник РАМН 2022; 77(4): 254–260. DOI: 10.15690/vramn2121
Akimkin V.G., Semenenko T.A., Ugleva S.V., Dubodelov D.V., Kuzin S.N., Iatsyshina S.B. et al. [COVID-19 in Russia: epidemiology and molecular genetic monitoring]. Annals of the Russian Academy of Medical Sciences 2022; 77(4): 254–260. (In Russ.). DOI: 10.15690/vramn2121
4. Черкасский Б.Л. Теоретическое обоснование структуры эпидемиологического надзора. В кн.: Сб. науч. тр. «Эпидемиологический надзор за инфекционными болезнями». М. 1987: 16–22.
Cherkasskу B.L. [Theoretical substantiation of the structure of epidemiological surveillance]. In: Epidemiological surveillance of infectious diseases. Moscow. 1987: 16–22. (In Russ.).
5. Акимкин В.Г., Попова А.Ю., Плоскирева А.А., Углева С.В., Семененко Т.А., Пшеничная Н.Ю. и др. COVID-19: эволюция пандемии в России. Сообщение I: проявления эпидемического процесса COVID-19. Журнал микробиологии, эпидемиологии и иммунобиологии 2022; 99(3): 269–286. DOI: 10.36233/0372-9311-276
Akimkin V.G., Popova A.Y., Ploskireva A.A., Ugleva S.V., Semenenko T.A., Pshenichnaia N.Yu. et al. [COVID-19: the evolution of the pandemic in Russia. Report I: manifestations of the COVID-19 epidemic process]. Journal of Microbiology, Epidemiology and Immunobiology 2022; 99(3): 269–286. (In Russ.). DOI: 10.36233/0372-9311-276
6. Болотовский В.Н., Зарицкий А.М., Зуев В.А., Кашкин К.П., Кондрусев А.И., Ковалева Е.П. и др. Эпидемиологический анализ. В кн.: Покровский В.И., ред. Руководство по эпидемиологии инфекционных болезней [в 2 т.]. T.1. М.: Медицина, 1993. 464 с.
Bolotovskii V.N., Zaritskii A.M., Zuev V.A., Kashkin K.P., Kondrusev A.I., Kovaleva E.P. et al. [Epidemiological analysis]. In: Pokrovskу V.I. еd. Handbook of Epidemiology of infectious diseases [in 2 volumes]. Vol. 1. Moscow: Medicine, 1993. 464 p. (In Russ.).
7. Акимкин В.Г., Хафизов К.Ф., Дубоделов Д.В., Воронин Е.М., Черкашина А.С., Углева С.В. и др. Молекулярно-генетический мониторинг и технологии цифровой трансформации в современной эпидемиологии. Вестник РАМН 2023; 78(4): 363–369. DOI: 10.15690/vramn13672
Akimkin V.G., Khafizov K.F., Dubodelov D.V., Voronin E.M., Cherkashina A.S., Ugleva S.V. et. al. [Molecular genetic monitoring and digital transformation technologies in modern epidemiology]. Annals of the Russian Academy of Medical Sciences 2023; 78(4): 363–369. (In Russ.). DOI: 10.15690/vramn13672
8. Virtanen P., Gommers R., Oliphant T.E., Haberland M., Reddy T., Cournapeau D. et. al. SciPy 1.0: Fundamental Algorithms for Scientific Computing in Python. Nat. Methods 2020; (17): 261–272. DOI: 10.1038/s41592-019-0686-2
9. The pandas development team. 2024. pandas-dev/pandas: Pandas (v2.2.2). Zenodo. DOI: 10.5281/zenodo.10957263
10. Seabold S., Perktold J. Statsmodels: Econometric and statistical modeling with python. 2010. Conference: Python in Science Conference. DOI: 10.25080/Majora-92bf1922-011
11. Профилактика инфекционных болезней. Эпидемиология и профилактика COVID-19: Методические рекомендации МР 3.1.0170-20. М.: Роспотребнадзор, 2020.
[Prevention of infectious diseases. Epidemiology and prevention of COVID-19. Methodological recommendations of MP 3.1.0170-20]. Moscow, 2020. (In Russ.).
12. Mei Q., Li J., Du R., Yuan X., Li M., Li J. Assessment of patients who tested positive for COVID-19 after recovery. Lancet Infect. Dis. 2020; 20(9): 1004–1005. DOI: 10.1016/S1473-3099(20)30433-3
13. Calba C., Goutard F.L., Hoinville L., Hendrikx P., Lindberg A., Saegerman C. et al. Surveillance systems evaluation: a systematic review of the existing approaches. BMC Public Health 2015; 15(448): 1–13. DOI: 10.1186/s12889-015-1791-5
14. Hendrikx P., Gay E., Chazel M., Moutou F., Danan C., Richomme C. et al. OASIS: an assessment tool of epidemiological surveillance systems in animal health and food safety. Epidemiol. Infect. 2011; 139(10): 1486–1496. DOI: 10.1017/S0950268811000161
15. Добролюбова Е.И., Южаков В.Н. Комплексная оценка результативности и эффективности санитарно-эпидемиологического надзора. Социум и власть 2020; 6(86): 40–54. DOI: 10.22394/1996-0522-2020-6-40-54
Dobrolyubova E.I., Yuzhakov V.N. [Comprehensive assessment of the effectiveness and efficiency of sanitary and epidemiological surveillance]. Society and Рower 2020; 6(86): 40–54. (In Russ.). DOI: 10.22394/1996-0522-2020-6-40-54
16. Declich S., Carter A.O. Public health surveillance: historical origins, methods and evaluation. Bull. World Health Organ 1994; 72(2): 285–304.
About the Autors
Dmitriy V. Dubodelov, Сand. Med. Sci., Senior Researcher, Laboratory of Viral Hepatitis, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; dubodelov@cmd.su; https://orcid.org/0000-0003-3093-5731
Professor Vasily G. Akimkin, Academician of the Russian Academy of Sciences, MD, Director, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; crie@pcr.su; https://orcid.org/0000-0003-4228-9044
Professor Tatiana A. Semenenko, MD, Head, Epidemiology Department, N.F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russia; Рrofessor, Department of Infectology and Virology, Institute of Professional Education, I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russia (Sechenov University), Moscow, Russia; semenenko@gamaleya.org; https://orcid.org/0000-0002-6686-9011
Anna S. Esman, Researcher, Laboratory of Molecular Methods for Studying of Genetic Polymorphisms, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia: esman@cmd.su; https://orcid.org/0000-0002-5456-7649
Professor Stanislav N. Kuzin, MD, Head, Laboratory of Viral Hepatitis, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia: kuzin@cmd.su; https://orcid.org/0000-0002-0616-9777
Svetlana V. Ugleva, MD, Associate Professor, Head, Scientific and Analytical Department, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia: ugleva@cmd.su; https://orcid.org/0000-0002-1322-0155
Evgeniy M. Voronin, Cand. Med. Sci., Head, Scientific Group of Mathematical Methods and Epidemiological Forecasting, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; voronin@cmd.su; https://orcid.org/0000-0001-5925-7757
Professor Andrey N. Gerasimov, Cand. Phys. and Math. Sci, Lead Researcher, Scientific Group of Mathematical Methods and Epidemiological Forecasting, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; gerasimov.a@cmd.su, https://orcid.org/0000-0003-4549-7172
Anna S. Cherkashina, Cand. Chem. Sci., Director, Scientific Group of Genetic Engineering and Biotechnology, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; cherkashina@pcr.ms; https://orcid.org/0000-0001-7970-7495
Kamil F. Khafizov, Cand. Biol. Sci., Head, Laboratory of Genomic Studies, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; khafizov@cmd.su; https://orcid.org/0000-0001-5524-0296
Natalia V. Sycheva, Junior Researcher, Laboratory of Infections Associated with the Provision of Medical Care, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; sycheva.n@cmd.su; https://orcid.org/0000-0001-8557-6540
Marina I. Korabelnikova, Researcher, Laboratory of Viral Hepatitis, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; korabelnikova@cmd. su; https://orcid.org/0000-0002-2575-8569
Angelina A. Monakhova, Postgraduate Student, , Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; monaxova.angelina@mail.ru; https://orcid.org/0009-0000-9950-2649
Roman M. Beregovykh, Specialist in Data Analysis and Processing, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; beregovykh@cmd.su; https://orcid.org/0009-0000-3956-2148
Similar Articles
